『2 Minutes with Joey - MRNA Stock News』のカバーアート

2 Minutes with Joey - MRNA Stock News

2 Minutes with Joey - MRNA Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Moderna (MRNA) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • MRNA Today - Jul 15: Moderna Sees Slight Dip

    MRNA Today - Jul 15: Moderna Sees Slight Dip
    2026/07/15
    Hey there! It’s Joey here, your friendly stock buddy and longtime investor. Let's chat about Moderna today. It was a bit of a red day for MRNA, down about two-thirds of a percent. Not a huge drop, but still a dip.

    So, here’s what went down. The stock wasn't really vibing with the market today. It got smoked worse than the overall market averages. Volume was way lighter than usual too, which usually means folks are kinda sitting on their hands instead of jumping in. You know, that classic slow bleed vibe.

    Now, why did this happen? Well, it seems like there’s a mix of stuff going on. For one, the CDC isn’t publishing that report on COVID-19 vaccine effectiveness. That’s a big deal for a company like Moderna, which has been riding the vaccine wave. When news like that drops, it can make investors a bit jittery, and they start hitting that sell button fast.

    Also, there was some chatter about the Affordable Care Act subsidies set to expire soon. This could impact healthcare stocks, including Moderna, since it might affect how people access vaccines and treatments down the line.

    On a brighter note, there was some buzz about Moderna’s early-stage research on a Hantavirus vaccine. That’s exciting stuff! Investors love to hear about new projects, especially in the vaccine space. But, honestly, the excitement didn’t translate to the stock today.

    And just to throw something out there, Moderna’s been mentioned as one of the vaccine stocks to keep an eye on for 2026. That could mean potential upside in the future if they hit it big with new products.

    So, yeah, it was a bit of a bummer day for Moderna. But that’s how the market rolls sometimes. Remember, this is just for fun and info, not financial advice. Keep doing your thing, and I’ll catch you later!
    続きを読む 一部表示
    2 分
  • MRNA Today - Jul 14: Profit-Taking After Rally

    MRNA Today - Jul 14: Profit-Taking After Rally
    2026/07/14
    Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today we’re talking about Moderna, MRNA for those in the know. It was a red day for them, barely moving, down just a smidge, about 0.21%.

    So, what happened? Well, Moderna got smoked today. After a solid rally last week, where it jumped up 20%, some folks decided it was time to take profits. You know how it goes, right? When things get hot, people start cashing in. Plus, there’s some chatter about this hantavirus buzz that’s got people talking, but it didn’t help the stock today.

    Now, why did the stock take this hit? A few reasons. For one, it seems like investors were getting a bit jittery after such a nice run-up. The market kinda had a rough day overall too, which didn’t help. Plus, there was news that the CDC won’t publish a report on COVID-19 vaccine effectiveness. That’s a big deal for Moderna, who’s been riding that vaccine wave. It’s like when your favorite show gets canceled—just leaves you feeling a little empty, ya know?

    Oh, and speaking of news, Moderna's working on a bird flu vaccine that’s hit late-stage testing. That’s something to keep an eye on. It could be a game-changer if it takes off.

    So, yeah, today was a bit of a bummer for Moderna. But hey, that’s the market for you—one day you’re up, the next you’re down. Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • MRNA Today - Jul 13: Profit-Taking Hits Moderna

    MRNA Today - Jul 13: Profit-Taking Hits Moderna
    2026/07/13
    Hey there! It’s Joey, your friendly investor buddy here, breaking down what went down today with Moderna, ticker MRNA. Spoiler alert: it was a bit of a red day. The stock barely moved, closing down just a smidge at 0.53%.

    So, what happened? Well, it seems like people were hitting that sell button pretty fast today. After a solid 20% rally earlier this week, some investors decided to cash in their chips. You know how it goes; when you see a nice gain, it’s hard to resist taking a little profit. Plus, there was some chatter about the hantavirus that kinda added to the mix. Nothing like a little buzz to shake things up, right?

    Now, let’s talk about why this happened. There was a lot of buzz around Moderna’s flu vaccine decision, which is causing some folks to rethink its valuation. It’s like everyone is trying to figure out what this means for the stock in the long run. And if that wasn’t enough, Y Intercept Hong Kong Ltd sold off a hefty chunk of shares—around 444,000. That’s a big sell-off and definitely gets people talking.

    On top of all that, there’s been some chatter about Arbutus Biopharma validating their intellectual property claims against Moderna. That’s a whole other layer of drama that could impact investor sentiment. So yeah, it’s definitely a lot for people to chew on right now.

    One quick thing on the horizon: Moderna is still in the spotlight for its vaccine developments, and investors are keeping a close eye on how that plays out. It’s like a rollercoaster ride; you never really know what’s coming next, but you gotta hold on tight!

    So, in short, today was a bit of a profit-taking day for Moderna. If you’re holding shares, you might feel that little sting from the dip. Just remember, the stock market is always full of ups and downs. That’s just how it goes!

    Alright, folks, that’s a wrap for today’s recap. Just remember, this is all for info and entertainment—no financial advice here! Catch you later!
    続きを読む 一部表示
    2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません